These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32644030)

  • 1. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
    Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
    Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
    [No Abstract]   [Full Text] [Related]  

  • 2. Capacity to report on mortality attributable to chronic hepatitis B and C infections by Member States: An exercise to monitor progress towards viral hepatitis elimination.
    Duarte G; Williams CJ; Vasconcelos P; Nogueira P
    J Viral Hepat; 2018 Jul; 25(7):878-882. PubMed ID: 29479771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C and hepatitis B-related mortality in Spain.
    García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030.
    Ou TY; Huy LD; Mayne J; Shih CL; Mai Xuan H; Thi Hong Nguyen N; Nguyen Hoai L; Thi My Bui L; Chang YM; Abdi AA; Hsu SC; Lin HJ; Huang CC
    J Infect Public Health; 2024 Jul; 17(7):102443. PubMed ID: 38838606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
    Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
    Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.
    Perz JF; Armstrong GL; Farrington LA; Hutin YJ; Bell BP
    J Hepatol; 2006 Oct; 45(4):529-38. PubMed ID: 16879891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
    Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic liver disease mortality attributable to hepatitis B and C in New Zealand.
    Weir RP; Brunton CR; Blakely TA
    J Gastroenterol Hepatol; 2002 May; 17(5):582-8. PubMed ID: 12084033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.
    Duffell E; Cortez-Pinto H; Simonova M; Dalgard O; Dahl EH; de Martel C; Mozalevskis A; Buti M; Pavlova S; Hadzhilova T; Simões C; Katzarov K; Mardh O
    J Viral Hepat; 2021 Aug; 28(8):1177-1189. PubMed ID: 34003542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation effect of hepatitis B and C on mortality.
    Huang YT; Freeman JR; Yang HI; Liu J; Lee MH; Chen CJ
    Eur J Epidemiol; 2016 Jun; 31(6):625-33. PubMed ID: 26792787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of virus-associated liver cancer in the Arab world, 1990-2010.
    Khan G; Hashim MJ
    Asian Pac J Cancer Prev; 2015; 16(1):265-70. PubMed ID: 25640363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.
    GBD 2019 Europe Hepatitis B & C Collaborators
    Lancet Public Health; 2023 Sep; 8(9):e701-e716. PubMed ID: 37633679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital discharges of hepatocellular carcinoma and non-alcohol related cirrhosis in the EU/EEA and United Kingdom: a descriptive analysis of 2004-2015 data.
    Nakitanda AO; Duffell E
    Infect Dis (Lond); 2020 Nov; 52(11):816-827. PubMed ID: 32838640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
    Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India.
    Islami F; Dikshit R; Mallath MK; Jemal A
    Cancer Epidemiol; 2016 Feb; 40():79-86. PubMed ID: 26683034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
    Hatzakis A; Wait S; Bruix J; Buti M; Carballo M; Cavaleri M; Colombo M; Delarocque-Astagneau E; Dusheiko G; Esmat G; Esteban R; Goldberg D; Gore C; Lok AS; Manns M; Marcellin P; Papatheodoridis G; Peterle A; Prati D; Piorkowsky N; Rizzetto M; Roudot-Thoraval F; Soriano V; Thomas HC; Thursz M; Valla D; van Damme P; Veldhuijzen IK; Wedemeyer H; Wiessing L; Zanetti AR; Janssen HL
    J Viral Hepat; 2011 Sep; 18 Suppl 1():1-16. PubMed ID: 21824223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
    Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
    HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma.
    Tong CY; Khan R; Beeching NJ; Tariq WU; Hart CA; Ahmad N; Malik IA
    Epidemiol Infect; 1996 Oct; 117(2):327-32. PubMed ID: 8870630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
    Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
    PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.